| 47.00 |  +0.83 / +1.80% |
Data as of 4:00pm ET | Day’s Change |
| 46.82 |  -0.18 / -0.38% |
Volume: 96.1K |
| Priority Review for AZN/BMY Drug - Analyst Blog 12:03pm / Zacks.com | Why Idenix Is Poised to Pull Back Jun 05 / MotleyFool.com |
| 3 Stocks to Get on Your Watchlist Jun 05 / MotleyFool.com | Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard Jun 04 / TheStreet.com |
| 3 Noteworthy Upgrades Worth a Look Jun 05 / MotleyFool.com | Incyte Reveals Data on Oncology Candidate - Analyst Blog Jun 04 / Zacks.com |
| Encouraging data from Bristol-Myers - Analyst Blog Jun 05 / Zacks.com | Cramer's 'Mad Money' Recap: Out With the New Jun 03 / TheStreet.com |
| The Medicines Co. Inks Deal with ProFibrix - Analyst Blog Jun 05 / Zacks.com | Carmakers fail to buoy S&P 500 Jun 03 / FT.com |
| Previous close | 46.17 |
| Today’s open | 46.38 |
| Day’s range | 45.92 - 47.29 |
| Volume | 12,420,544 |
| Average volume (3 months) | 11,427,170 |
| Market cap | $75.8B |
| Dividend yield | 2.98% |
| Earnings growth (last year) | -46.30% |
| Earnings growth (this year) | -8.55% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | -17.05% |
| P/E ratio | 54.0 |
| Price/Sales | 3.09 |
| Price/Book | 5.52 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk A/S | +1.23 | +0.75% |
| ABBVAbbVie Inc | +0.46 | +1.07% |
| AZNAstraZeneca PLC | +0.69 | +1.36% |
| LLYEli Lilly and Co | +0.28 | +0.54% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $17.6B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 11.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Lamberto Andreotti |
Chief Financial Officer & Executive Vice President Charles A. Bancroft, MBA, CPA |
Corporate headquarters New York, New York |
.
